Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1656  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


This article has been cited by
1CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells
Xie Yingjun,Xie Yuhuan,Chen Yuchang,Li Dongzhi,Wang Ding,Song Bing,Yang Yi,Lu Dian,Xue Yanting,Xiong Zeyu,Liu Nengqing,Chen Diyu,Sun Xiaofang
Annals of Hematology.2019;98(12)2661
[DOI]
2Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and -thalassemia
Lin Ye,Jiaming Wang,Yuting Tan,Ashley I. Beyer,Fei Xie,Marcus O. Muench,Yuet Wai Kan
Proceedings of the National Academy of Sciences.2016;113(38)10661
[DOI]
3Haemoglobin disorders in Australia: where are we now and where will we be in the future?
G. Crighton,E. Wood,R. Scarborough,P. J. Ho,D. Bowden
Internal Medicine Journal.2016;46(7)770
[DOI]
4Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Joseph Sleiman,Ali Tarhini,Rayan Bou-Fakhredin,Antoine Saliba,Maria Cappellini,Ali Taher
International Journal of Molecular Sciences.2018;19(1)182
[DOI]
5Revisiting beta thalassemia intermedia: past, present, and future prospects
Naouel Ben Salah,Rayan Bou-Fakhredin,Fethi Mellouli,Ali T. Taher
Hematology.2017;22(10)607
[DOI]
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal